APA (7th ed.) Citation

Yang, M., Chen, T., Wang, H., Hsieh, J. C., Huang, H., Hsieh, M., . . . Chu, P. (2024). Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen. BMC cancer, 24(1), 1227-11. https://doi.org/10.1186/s12885-024-12425-0

Chicago Style (17th ed.) Citation

Yang, Muh-Hwa, et al. "Prognostic Factors and Risk-stratification Model of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Cetuximab Containing Regimen." BMC Cancer 24, no. 1 (2024): 1227-11. https://doi.org/10.1186/s12885-024-12425-0.

MLA (9th ed.) Citation

Yang, Muh-Hwa, et al. "Prognostic Factors and Risk-stratification Model of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Cetuximab Containing Regimen." BMC Cancer, vol. 24, no. 1, 2024, pp. 1227-11, https://doi.org/10.1186/s12885-024-12425-0.